Last Updated : Wednesday, April 1, 2020 20:05:08

STRIDE PHARMA’s Banglore facility gets EIR

BANGALORE / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Bangalore headquartered Stride Pharma Science Ltd said of having got Establishment Inspection Report (EIR) for their Bangalore facility after the facility was inspected by USFDA (US Food and Drugs Administration) in the month of January 2020, for specific extended release drug applications.

In a press-release titled, “Strides announces successful completion of US FDA inspection conducted in January 2020 at flagship facility in Bangalore”, submitted as enclosure with the regulatory filing as submitted to the Indian Bourses, further read that, Inspection conducted (by USFDA) in January 2020 was for specific Extended Release applications.

The press-release further read that, Strides Pharma Science Limited (Strides) today announced that it has received the Establishment Inspection Report (EIR) for the inspection conducted by the USFDA in January 2020 at Company’s flagship facility KRS Gardens, Bangalore.

The inspection was related to specific Extended Release applications made from the site. Receipt of EIR confirms the successful closure of the inspections.

The flagship facility in Bangalore is the largest manufacturing facility for the company with capabilities to produce finished dosage formulation products across multiple dosage formats including tablet, capsules, ointments, creams and liquids.

The facility is also capable of manufacturing complex formulations of Extended Release tablets which is one of the focus area’s for the company.

Strides has a large Extended Release portfolio for the US and other regulated markets with a capability to manufacture these products at multiple sites.

Strides had recently also received EIR for Bangalore facility from USFDA for the inspection conducted in March 2020 and the same was intimated to Stock Exchanges on March 26, 2020.

Also Read On :

In case if a reader / viewer / visitor to the website wishes to VERIFY the above narrated news-report, please CLICK here.


FacebookGoogle+LinkedinTwitterYouTube, Blogspot, Telegram, Instagram 


Do NOT follow this link or you will be banned from the site!